Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
31 Jul 2024 |
On P&L |
The Company releases the press release related to the first half 2024 financial results
|
Download |
|
31 Jul 2024 |
On P&L |
The Company releases the first half 2024 financial results presentation
|
Download |
|
26 Jun 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
|
24 Jun 2024 |
On business and financial situation |
ROVI publishes the press release in relation to information and guidance on its strategic plan for expansion and growth
|
Download |
|
08 May 2024 |
On P&L |
The Company releases the press release related to the first three months of 2024 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
15 Feb 2022 |
On business and financial situation |
ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
|
Download |
|
14 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022
|
Download |
|
07 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022
|
Download |
|
31 Jan 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022
|
Download |
|
24 Jan 2022 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Oct 2018 |
Share capital increases and reductions |
Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase
|
Download |
|
05 Oct 2018 |
Buy-back programmes, stabilisation and treasury stock |
Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights
|
Download |
|
04 Oct 2018 |
Liquidity contracts and specialists |
The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U.
|
Download |
|
04 Oct 2018 |
Share capital increases and reductions |
Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights
|
Download |
Pages
